p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex. (Q51528185)

6 April 2018

title

p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex. (English)

1 reference

6 April 2018

author name string

Zhe Zhou

1

1 reference

6 April 2018

Ji-Xiang Cao

2

1 reference

6 April 2018

Shu-Yan Li

3

1 reference

6 April 2018

Guo-Shun An

4

1 reference

6 April 2018

Ju-Hua Ni

5

1 reference

6 April 2018

Hong-Ti Jia

6

1 reference

6 April 2018

language of work or name

English

0 references

publication date

26 September 2013

1 reference

6 April 2018

Experimental Cell Research

published in

1 reference

6 April 2018

volume

319

1 reference

6 April 2018

issue

20

1 reference

6 April 2018

page(s)

3104-3115

1 reference

6 April 2018

Polo-like kinases and the orchestration of cell division

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Polo-like kinases and oncogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Cell cycle regulation of the human polo-like kinase (PLK) promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Polo on the Rise-from Mitotic Entry to Cytokinesis with Plk1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Roles of polo-like kinase 1 in the assembly of functional mitotic spindles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Polo-like kinase controls vertebrate spindle elongation and cytokinesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Chemical genetics reveals the requirement for Polo-like kinase 1 activity in positioning RhoA and triggering cytokinesis in human cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Polo-like Kinase 1 Triggers the Initiation of Cytokinesis in Human Cells by Promoting Recruitment of the RhoGEF Ect2 to the Central Spindle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Polo-like kinase 1 reaches beyond mitosis--cytokinesis, DNA damage response, and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Polo-like kinase 1 depletion induces DNA damage in early S prior to caspase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Targeting Polo-like kinase in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Polo-like kinase (PLK) expression in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Polo‐like kinase 1 (PLK1) is overexpressed in primary colorectal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Specificity in the activation and control of transcription factor E2F-dependent apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Transcriptional repression mediated by the p53 tumour suppressor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

MEF/ELF4 transactivation by E2F1 is inhibited by p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Transcriptional regulation of human polo-like kinases and early mitotic inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

p53-dependent repression of polo-like kinase-1 (PLK1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Phosphorylation- and polo-box-dependent binding of Plk1 to Bub1 is required for the kinetochore localization of Plk1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

8-Chloro-adenosine-induced E2F1 promotes p14ARF gene activation in H1299 cells through displacing Sp1 from multiple overlapping E2F1/Sp1 sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Synergistic up-regulation of muscle LIM protein expression in C2C12 and NIH3T3 cells by myogenin and MEF2C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Normal cells, but not cancer cells, survive severe Plk1 depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Inhibitory role of E2F-1 in the regulation of tumor suppressor p53 during DNA damage response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.09.012

10.1016/J.YEXCR.2013.09.012

7 January 2021

Identifiers

DOI

1 reference

6 April 2018

1 reference

6 April 2018